充血性心力衰竭患者血清IL-1β变化及胺碘酮对PBMC分泌IL-1β的影响
出处
《山东医药》
CAS
北大核心
2000年第23期28-29,共2页
Shandong Medical Journal
基金
山东省99科技攻关项目!(NO.9912 0 5 914 )
参考文献6
-
1Packer M.Sudden unexpected death in patients with congestive heart failure:a second frontier.Circulation,1985,72:681.
-
2Bigger JT.Why patients with congestive heart failure die:arrythmias and sudden cardiac death.Circulation,1987,75:28.
-
3Cleland JGF,Dargie HJ,Findly IN,et al.Clinical,haemodynamic,and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.Br Heart J,1987,57:436.
-
4Shioi T,Matsumori A,Kiharaa Y,et al.Increased expression of interleukin-1β and monocyte chemotactic and activiting factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload.Cir Res,1997,81:664.
-
5Matsumori A,Ono K,Nishio R,et al.Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells,Circulation,1997,96:1386.
-
6Doyama K,Fujigara H,Fukumoto M,et al.Tumor necrosis factor-alpha expression in cardiac tissue of patients with heart failure.Int J Cardiol,1996,54:217.
-
1王建平.中西医结合治疗心房颤动32例[J].实用中医内科杂志,2003,17(3):181-181. 被引量:2
-
2张冀军,郭广庆,郭庆平,牛青英.美西律、胺碘酮对QT离散度的影响及其临床意义[J].长治医学院学报,2002,16(4):263-264.
-
3范标,季勇,姜黎晴.阵发性心房颤动32例胺碘酮治疗前后心电图P波离散度的变化[J].武警医学,2003,14(3):163-164.
-
4赵瑞革,武红梅,赵利华.胺碘酮终止持续性心房颤动的临床分析[J].锦州医学院学报,2001,22(6):25-26.
-
5何洪静,徐贵丽,王慧敏,邓琴,邓婕.利多卡因与胺碘酮对恶性室性心律失常疗效和安全性的系统评价[J].中国药师,2008,11(1):31-35. 被引量:1
-
6柏月平,胡思东,金惠林.胺碘酮联合坎地沙坦治疗阵发性房颤临床疗效观察[J].心脑血管病防治,2010,10(1):65-66. 被引量:2
-
7贾付坤.胺碘酮预防心肌梗塞后猝死的疗效评价[J].中国实用内科杂志,1997,17(8):505-506. 被引量:10
-
8张玉东,孟庆敏,邓搏夫.胺碘酮治疗心力衰竭合并室性心律失常的疗效评价[J].中国现代医学杂志,1999,9(11):55-56. 被引量:2
-
9赵瑞,郭旻,于涛.负荷量胺碘酮控制快速心房颤动的疗效观察[J].宁夏医学杂志,2007,29(10):915-916. 被引量:2
-
10刘仲华,隋彩珍.胺碘酮治疗心肌梗死后室性心动过速15例[J].中国临床药理学与治疗学,2001,6(1):73-73.